Physician profile
Mary E Boyle
NPI 1861475113
$1,254.36
in general payments reported to CMS, 2019-2025
9 companies · $85.53 in 2025
The $85.53 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $533 · 2023: $195 · 2024: $441 · 2025: $85.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $369.61 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $215.87 | 2022-2024 | Dexcom G7 Gss (161) |
| Medtronic, INC. | $190.19 | 2022 | |
| Kyowa Kirin, INC. | $124.95 | 2024 | Crysvita |
| Abbott Laboratories | $123.93 | 2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $85.53 | 2025 | |
| Novo Nordisk INC | $74.04 | 2023-2024 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.41 | 2023 | Jardiance |
| Boehringer Ingelheim International Gmbh | $21.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.